T1	Participants 59 88	adults with autistic disorder
T2	Participants 496 532	Thirty adults with autistic disorder
T3	Participants 779 900	15 patients in the fluvoxamine-treated group were categorized as responders compared with none of 15 in the placebo group
#1	AnnotatorNotes T3	Total of 30 participants.
